MENU × BUSINESS
Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
TECHNOLOGY
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
PLATFORM
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
LEADERSHIP
CEO ReviewCompany Review
MAGAZINE
ASIA INDIA
STARTUPS CLIENT SPEAK CONTACT US

The Silicon Review Asia

Accenture and Merck Join hands with AWS to build New Cloud Precision Medicine Platform

Accenture and Merck Join hands with AWS to build New Cloud Precision Medicine Platform

Accenture and pharmaceutical company Merck has made an announcement that both the companies will collaborate with Amazon Web Services (AWS) to build a cloud-based platform for medicine. The development aims to make innovations faster in drug and development research.

Both the companies decided to collaborate with AWS few weeks after Deloitte and Vineti announced a similar cloud-based precision medicine platform development.

According to Accenture and Merck, the creation of the cloud platform will be carried out in open application program interfaces, it will allow researchers to connect, to lower barriers to entry for app developers, content providers and others looking to bring new capabilities to market.  

The new cloud platform will help the researchers to aggregate, access and analyze data from multiple applications, enabling new approaches to data-heavy research. The partnership will make Merck the first ever pharmaceutical company to use the new platform. The platform leverages secure AWS cloud services to boost speed and drive operational efficiency.

According to Accenture, the company is gathering different clients from pharmaceutical, biotech and another scientific background for helping to platform's capabilities, offering an opportunity for pre-competitive industry collaboration.

“Pharmaceutical and biotech R&D is evolving rapidly, with advances in biological sciences generating an increase in the volume and diversity of research data,” said Brad Michel, managing director of Accenture Scientific Informatics Services.

YOU MAY ALSO LIKE

Marketing Partnership: NBA, McDonald’s Will Jointly open NBA Experience Zones India

There is good news for all basketball fans in India. Very soon, NBA themed promotions and experience zones will be launched in India. The announcement...

Dunzo to Raise Funds from Google, others

Dunzo, the app which is trying to make life easier for the people upto some extent plans to raise about Rs. 183 crore from different investors which a...

Sapta Shakti Command Will Be Displaying Defence Technology Equipment at Jaipur Military Station

This event is organised with an aim to provide an opportunity where one and all can experience the developments in the field of defence and security-r...

Samsung is All Set to Roll out Its Galaxy A9 Smartphone On November 20

After Samsung unveiled its new Galaxy A9 smartphone in Singapore last month, the company is all set to launch it in India on November 20. In Singapore...

RECOMMENDED